Peregrine Pharmaceuticals (PPHM) Posts Narrower than Expected Loss of 10c/Share
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Contract manufacturing revenue: 5.61M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Contract manufacturing revenue: 5.61M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Peregrine Pharmaceuticals (NASDAQ: PPHM) reported Q4 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.07 million versus the consensus estimate of $2.64 million.
For earnings history and earnings-related data on Peregrine Pharmaceuticals (PPHM) click here.
For earnings history and earnings-related data on Peregrine Pharmaceuticals (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
